UniProt ID | KC1E_HUMAN | |
---|---|---|
UniProt AC | P49674 | |
Protein Name | Casein kinase I isoform epsilon | |
Gene Name | CSNK1E | |
Organism | Homo sapiens (Human). | |
Sequence Length | 416 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1 and DVL2. Central component of the circadian clock. In balance with PP1, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. Inhibits cytokine-induced granuloytic differentiation.. | |
Protein Sequence | MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARNPEDVDRERREHEREERMGQLRGSATRALPPGPPTGATANRLRSAAEPVASTPASRIQPAGNTSPRAISRVDRERKVSMRLHRGAPANVSSSDLTGRQEVSRIPASQTSVPFDHLGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Phosphorylation | RLGRKIGSGSFGDIY ECCCEECCCCCCCEE | 34.43 | - | |
44 | Phosphorylation | IKLECVKTKHPQLHI EEEEEHHCCCCCEEH | 17.75 | 20507565 | |
45 | Ubiquitination | KLECVKTKHPQLHIE EEEEHHCCCCCEEHH | 47.79 | - | |
54 | Ubiquitination | PQLHIESKFYKMMQG CCEEHHHHHHHHHCC | 39.66 | - | |
57 | Ubiquitination | HIESKFYKMMQGGVG EHHHHHHHHHCCCCC | 30.91 | - | |
67 | Phosphorylation | QGGVGIPSIKWCGAE CCCCCCCCCCCCCCC | 34.57 | 24719451 | |
122 | Ubiquitination | RIEYIHSKNFIHRDV HHHHHHHCCCCCCCC | 41.54 | 2189047 | |
130 | Ubiquitination | NFIHRDVKPDNFLMG CCCCCCCCCCCEEEC | 51.44 | 21890473 | |
140 | Ubiquitination | NFLMGLGKKGNLVYI CEEECCCCCCCEEEE | 63.65 | 21906983 | |
141 | Ubiquitination | FLMGLGKKGNLVYII EEECCCCCCCEEEEE | 51.76 | - | |
146 | Phosphorylation | GKKGNLVYIIDFGLA CCCCCEEEEEECCCC | 8.70 | 29496907 | |
171 | Ubiquitination | HIPYRENKNLTGTAR CCCCCCCCCCCCEEE | 48.89 | - | |
179 | Phosphorylation | NLTGTARYASINTHL CCCCEEEEEEHHHHC | 11.39 | 29496907 | |
181 | Phosphorylation | TGTARYASINTHLGI CCEEEEEEHHHHCCC | 13.87 | 28857561 | |
184 | Phosphorylation | ARYASINTHLGIEQS EEEEEHHHHCCCCCH | 19.46 | 30576142 | |
232 | Ubiquitination | YERISEKKMSTPIEV HHHHHHCCCCCCHHH | 33.75 | - | |
234 | Phosphorylation | RISEKKMSTPIEVLC HHHHCCCCCCHHHHC | 39.65 | 20068231 | |
235 | Phosphorylation | ISEKKMSTPIEVLCK HHHCCCCCCHHHHCC | 25.45 | 29978859 | |
242 | Acetylation | TPIEVLCKGYPSEFS CCHHHHCCCCCHHHH | 58.27 | 130647 | |
244 | Phosphorylation | IEVLCKGYPSEFSTY HHHHCCCCCHHHHHH | 6.78 | 29978859 | |
246 | Phosphorylation | VLCKGYPSEFSTYLN HHCCCCCHHHHHHHH | 42.67 | 29978859 | |
249 | Phosphorylation | KGYPSEFSTYLNFCR CCCCHHHHHHHHHHH | 16.46 | 29978859 | |
250 | Phosphorylation | GYPSEFSTYLNFCRS CCCHHHHHHHHHHHH | 37.03 | 29978859 | |
251 | Phosphorylation | YPSEFSTYLNFCRSL CCHHHHHHHHHHHHC | 9.84 | 29496907 | |
263 | Ubiquitination | RSLRFDDKPDYSYLR HHCCCCCCCCHHHHH | 41.45 | 21890473 | |
266 | Phosphorylation | RFDDKPDYSYLRQLF CCCCCCCHHHHHHHH | 14.03 | - | |
267 | Phosphorylation | FDDKPDYSYLRQLFR CCCCCCHHHHHHHHH | 25.68 | 29496907 | |
284 | Phosphorylation | FHRQGFSYDYVFDWN HHHCCCCCEEEEEHH | 14.72 | 29496907 | |
286 | Phosphorylation | RQGFSYDYVFDWNML HCCCCCEEEEEHHHH | 8.52 | 29496907 | |
321 | Methylation | EERMGQLRGSATRAL HHHHHHHCCCCCCCC | 29.18 | - | |
323 | Phosphorylation | RMGQLRGSATRALPP HHHHHCCCCCCCCCC | 21.74 | 23927012 | |
325 | Phosphorylation | GQLRGSATRALPPGP HHHCCCCCCCCCCCC | 20.40 | 23927012 | |
334 | Phosphorylation | ALPPGPPTGATANRL CCCCCCCCCHHHHHH | 42.45 | 22817900 | |
337 | Phosphorylation | PGPPTGATANRLRSA CCCCCCHHHHHHHHC | 26.30 | 22817900 | |
342 | Methylation | GATANRLRSAAEPVA CHHHHHHHHCCCCCC | 22.47 | - | |
343 | Phosphorylation | ATANRLRSAAEPVAS HHHHHHHHCCCCCCC | 36.10 | 21082442 | |
350 | Phosphorylation | SAAEPVASTPASRIQ HCCCCCCCCCHHHCC | 34.85 | 21712546 | |
351 | Phosphorylation | AAEPVASTPASRIQP CCCCCCCCCHHHCCC | 17.09 | 21712546 | |
354 | Phosphorylation | PVASTPASRIQPAGN CCCCCCHHHCCCCCC | 30.99 | 26055452 | |
362 | Phosphorylation | RIQPAGNTSPRAISR HCCCCCCCCHHHHHH | 38.91 | 29255136 | |
363 | Phosphorylation | IQPAGNTSPRAISRV CCCCCCCCHHHHHHH | 19.18 | 29255136 | |
368 | Phosphorylation | NTSPRAISRVDRERK CCCHHHHHHHHHHHH | 25.85 | 26074081 | |
377 | Phosphorylation | VDRERKVSMRLHRGA HHHHHHHHHHEECCC | 10.96 | 20068231 | |
382 | Methylation | KVSMRLHRGAPANVS HHHHHEECCCCCCCC | 47.78 | - | |
389 | Phosphorylation | RGAPANVSSSDLTGR CCCCCCCCHHHCCCC | 24.75 | 29255136 | |
390 | Phosphorylation | GAPANVSSSDLTGRQ CCCCCCCHHHCCCCH | 24.48 | 29255136 | |
391 | Phosphorylation | APANVSSSDLTGRQE CCCCCCHHHCCCCHH | 29.18 | 29255136 | |
394 | Phosphorylation | NVSSSDLTGRQEVSR CCCHHHCCCCHHCCC | 35.00 | 29255136 | |
400 | Phosphorylation | LTGRQEVSRIPASQT CCCCHHCCCCCCCCC | 24.60 | - | |
405 | Phosphorylation | EVSRIPASQTSVPFD HCCCCCCCCCCCCCC | 28.74 | 26055452 | |
407 | Phosphorylation | SRIPASQTSVPFDHL CCCCCCCCCCCCCCC | 29.24 | 10542239 | |
408 | Phosphorylation | RIPASQTSVPFDHLG CCCCCCCCCCCCCCC | 21.84 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
44 | T | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
323 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
323 | S | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
323 | S | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
325 | T | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
325 | T | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
325 | T | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
334 | T | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
334 | T | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
334 | T | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
337 | T | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
337 | T | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
337 | T | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
368 | S | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
368 | S | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
368 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
389 | S | Phosphorylation | Kinase | PRKAA1 | Q5EG47 | GPS |
389 | S | Phosphorylation | Kinase | AMPKA1 | Q13131 | PSP |
405 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
405 | S | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
405 | S | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
407 | T | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
407 | T | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
407 | T | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
408 | S | Phosphorylation | Kinase | CK1-FAMILY | - | GPS |
408 | S | Phosphorylation | Kinase | CSNK1E | P49674 | GPS |
408 | S | Phosphorylation | Kinase | CK1_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KC1E_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KC1E_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; SER-343; SER-354;THR-362; SER-363; SER-389; SER-391; SER-405; THR-407 AND SER-408, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323; SER-343; SER-350;THR-351; SER-354; THR-362; SER-363; SER-389; SER-405 AND SER-408, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-343 AND SER-389, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-351; SER-354 ANDSER-389, AND MASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-362, AND MASSSPECTROMETRY. |